Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Glioblastoma 77Brain Neoplasms 75Glioma 68Astrocytoma 30Central Nervous System Neoplasms 24Gliosarcoma 21Neuroblastoma 19Lung Neoplasms 19Ependymoma 19Medulloblastoma 18Oligodendroglioma 17Meningioma 16Breast Neoplasms 15Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 10Sarcoma 7Neuroendocrine Tumors 7Neuroectodermal Tumors, Primitive, Peripheral 7Melanoma 7Glioma, Subependymal 7Ganglioneuroblastoma 7Wilms Tumor 6Thyroid Neoplasms 6Rhabdoid Tumor 6Osteosarcoma 6Neuroectodermal Tumors, Primitive 6Meningeal Carcinomatosis 6Lymphoma, Non-Hodgkin 6Lymphoma 6Histiocytosis, Langerhans-Cell 6

Interventions

Specimen Handling 1Radiosurgery 1Nivolumab 1Magnetic Resonance Spectroscopy 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clear-cell metastatic renal cell carcinoma × Magnetic Resonance Spectroscopy × CNS × Clear all
NCT06942104 2025-07-18

Imaging of Solid Tumors Using 18F-TRX

University of California, San Francisco

Phase 1 Recruiting
56 enrolled
CNSGenitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Glioma, Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡